title: Serum osteocalcin and fracture susceptibility in elderly women.
abstract: The purpose of this investigation was to evaluate the bone turnover by using bone metabolic markers in relation to previous fracture history and independent of bone mass. Patients and controls were recruited from a population-based study of 193 women, all living in the same city and aged 60, 70, and 80 years. The bone mineral content (BMC) was measured bilaterally in the distal forearm by single-photon absorptiometry (SPA). At the same time, serum samples were obtained for biochemical analysis. Of the 193 women, we identified 26 with at least one major fracture during the past few years. Each of these 26 women with a certified recent previous fracture was individually matched with a woman from the same study group of equal BMC and age but without a fracture history. In the two groups, the serum samples were analyzed for osteocalcin, C-terminal procollagen peptide (P1CP), alkaline phosphatase, bone-specific alkaline phosphatase, calcium, phosphate, and albumin. The serum concentration of osteocalcin was 20% lower in the women with a previous fracture than in the controls (P = 0.03). The other markers of bone formation gave similar values in the two groups. There was a significant correlation between the osteocalcin and P1CP concentrations (P = 0.001). Our findings indicate that the susceptibility to fractures independent of factors such as age and BMC may be related to a decreased bone turnover.
authors.affiliation: Department of Orthopaedic Surgery, Malmö General Hospital, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Akesson
authors.forename: S
authors.initials: S
authors.lastname: Ljunghall
authors.forename: P
authors.initials: P
authors.lastname: Gärdsell
authors.forename: I
authors.initials: I
authors.lastname: Sernbo
authors.forename: K J
authors.initials: KJ
authors.lastname: Obrant
mesh_terms: D015502:Absorptiometry, Photon; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D000469:Alkaline Phosphatase / Q000032:analysis / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001842:Bone and Bones / Q000201:enzymology / Q000378:metabolism; D002118:Calcium / Q000097:blood; D004198:Disease Susceptibility; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood*; D015663:Osteoporosis, Postmenopausal / Q000150:complications; D010446:Peptide Fragments / Q000097:blood; D010710:Phosphates / Q000097:blood; D011347:Procollagen / Q000097:blood; D012307:Risk Factors; D012709:Serum Albumin / Q000032:analysis
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; D010710:Phosphates; D011347:Procollagen; D012709:Serum Albumin; C042813:procollagen type I carboxy terminal peptide; D015675:Osteocalcin; D000469:Alkaline Phosphatase; D002118:Calcium